1. Home
  2. FLIC vs DRUG Comparison

FLIC vs DRUG Comparison

Compare FLIC & DRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLIC
  • DRUG
  • Stock Information
  • Founded
  • FLIC 1927
  • DRUG 2019
  • Country
  • FLIC United States
  • DRUG United States
  • Employees
  • FLIC N/A
  • DRUG N/A
  • Industry
  • FLIC Major Banks
  • DRUG Pharmaceuticals and Biotechnology
  • Sector
  • FLIC Finance
  • DRUG Health Care
  • Exchange
  • FLIC Nasdaq
  • DRUG Nasdaq
  • Market Cap
  • FLIC 275.5M
  • DRUG 260.6M
  • IPO Year
  • FLIC N/A
  • DRUG N/A
  • Fundamental
  • Price
  • FLIC $12.96
  • DRUG $35.99
  • Analyst Decision
  • FLIC Hold
  • DRUG Strong Buy
  • Analyst Count
  • FLIC 1
  • DRUG 4
  • Target Price
  • FLIC $13.00
  • DRUG $84.33
  • AVG Volume (30 Days)
  • FLIC 99.6K
  • DRUG 69.2K
  • Earning Date
  • FLIC 01-30-2025
  • DRUG 03-04-2025
  • Dividend Yield
  • FLIC 6.48%
  • DRUG N/A
  • EPS Growth
  • FLIC N/A
  • DRUG N/A
  • EPS
  • FLIC 0.75
  • DRUG N/A
  • Revenue
  • FLIC $84,928,000.00
  • DRUG N/A
  • Revenue This Year
  • FLIC N/A
  • DRUG N/A
  • Revenue Next Year
  • FLIC N/A
  • DRUG N/A
  • P/E Ratio
  • FLIC $17.28
  • DRUG N/A
  • Revenue Growth
  • FLIC N/A
  • DRUG N/A
  • 52 Week Low
  • FLIC $9.30
  • DRUG $0.93
  • 52 Week High
  • FLIC $15.03
  • DRUG $79.02
  • Technical
  • Relative Strength Index (RSI)
  • FLIC 47.48
  • DRUG 43.58
  • Support Level
  • FLIC $13.57
  • DRUG $40.10
  • Resistance Level
  • FLIC $14.00
  • DRUG $47.50
  • Average True Range (ATR)
  • FLIC 0.47
  • DRUG 3.56
  • MACD
  • FLIC -0.05
  • DRUG -0.51
  • Stochastic Oscillator
  • FLIC 32.04
  • DRUG 23.22

About FLIC First of Long Island Corporation (The)

First of Long Island Corp is a holding company that provides financial services. It offers services of saving accounts, current accounts, and capital gain accounts. The company also provides lending services, such as commercial and residential mortgage loans, industrial loans, small business credit scored loans, and other credit facilities. In addition, the company provides account reconciliation services, ATM Banking, bill payment, cash management services, mobile banking, online banking, and payroll services to privately owned businesses, professionals, consumers, and public bodies. Revenue earned by the company mainly consists of the interest on loans and investment securities, fees on deposit accounts, and income from investment management.

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Share on Social Networks: